Cetera Investment Advisers Ocular Therapeutix, Inc Transaction History

Cetera Investment Advisers

$42.2 Billion
Q2 2024

A detailed history of Cetera Investment Advisers transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 739,044 shares of OCUL stock, worth $6.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

739,044

Previous 725,990 1.8%

Holding current value

$6.41 Million

Previous $6.61 Million 23.48%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	BUY	$4.2 - $8.69 $54,826 - $113,439	13,054 Added 1.8%	739,044 $5.06 Million
Q1 2024 May 24, 2024	BUY	$3.85 - $10.93 $2.8 Million - $7.94 Million	725,990 New	725,990 $6.61 Million
Q4 2023 Feb 13, 2024	BUY	$2.08 - $4.52 $137,904 - $299,676	66,300 Added 10.87%	676,400 $3.02 Million
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $3,611 - $5,796	-1,150 Reduced 0.19%	610,100 $1.92 Million
Q2 2023 Aug 09, 2023	BUY	$4.6 - $7.64 $46,460 - $77,164	10,100 Added 1.68%	611,250 $3.15 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $16,600 - $37,306	5,950 Added 1.0%	601,150 $3.17 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $24,403 - $41,233	-9,350 Reduced 1.55%	595,200 $1.67 Million
Q3 2022 Nov 10, 2022	BUY	$4.09 - $6.5 $22,086 - $35,100	5,400 Added 0.9%	604,550 $2.51 Million
Q2 2022 Aug 11, 2022	BUY	$3.01 - $5.22 $97,524 - $169,128	32,400 Added 5.72%	599,150 $2.41 Million
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $284,970 - $433,650	59,000 Added 11.62%	566,750 $2.81 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $466,004 - $913,095	75,650 Added 17.51%	507,750 $3.54 Million
Q3 2021 Nov 16, 2021	BUY	$9.7 - $14.34 $4.19 Million - $6.2 Million	432,100 New	432,100 $4.32 Million

Others Institutions Holding OCUL

# of Institutions

151

Shares Held

136M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Ocular Therapeutix, Inc Transaction History